Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
08:26am, Wednesday, 19'th Nov 2025
Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.
Aspen Investment Management Inc Purchases 1,774 Shares of Boston Scientific Corporation $BSX
04:34am, Wednesday, 19'th Nov 2025
Aspen Investment Management Inc lifted its holdings in Boston Scientific Corporation (NYSE: BSX) by 20.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm
Avantax Advisory Services Inc. Raises Holdings in Boston Scientific Corporation $BSX
04:34am, Wednesday, 19'th Nov 2025
Avantax Advisory Services Inc. grew its stake in Boston Scientific Corporation (NYSE: BSX) by 16.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange
Artisan Partners Limited Partnership Sells 1,141,087 Shares of Boston Scientific Corporation $BSX
03:56am, Wednesday, 19'th Nov 2025
Artisan Partners Limited Partnership decreased its stake in shares of Boston Scientific Corporation (NYSE: BSX) by 11.8% during the second quarter, according to its most recent filing with the Securit
Alteri Wealth LLC Lowers Stock Position in Boston Scientific Corporation $BSX
03:09am, Wednesday, 19'th Nov 2025
Alteri Wealth LLC cut its position in shares of Boston Scientific Corporation (NYSE: BSX) by 6.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC
Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
11:48am, Tuesday, 18'th Nov 2025
Boston Scientific Corporation ( BSX ) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 8:00 AM EST Company Participants Ken Stein - Senior VP & Global Chief Medical Officer Lauren Ten
Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade
10:55am, Tuesday, 18'th Nov 2025
The consensus price target hints at a 25.3% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings
Campbell & CO Investment Adviser LLC Invests $249,000 in Boston Scientific Corporation $BSX
03:55am, Tuesday, 18'th Nov 2025
Campbell and CO Investment Adviser LLC bought a new stake in Boston Scientific Corporation (NYSE: BSX) during the second quarter, according to the company in its most recent Form 13F filing with the S
4 Medical Product Stocks to Watch From a Challenging Industry
10:21am, Monday, 17'th Nov 2025
The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.
Boston Scientific Up 7% in a Month: How Should You Play the Stock?
08:20am, Friday, 14'th Nov 2025
BSX's month-long rally, strong Q3 beats and expansion into chronic pain solutions sharpen investor focus.
Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors
10:31am, Wednesday, 12'th Nov 2025
Boston Scientific (BSX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BSX crossed above the 200-day moving average, suggest
Boston Scientific Corporation $BSX Shares Acquired by Advyzon Investment Management LLC
04:04am, Wednesday, 12'th Nov 2025
Advyzon Investment Management LLC grew its stake in Boston Scientific Corporation (NYSE: BSX) by 22.7% in the second quarter, according to the company in its most recent Form 13F filing with the Secur
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
10:31am, Tuesday, 11'th Nov 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes"
02:16pm, Monday, 10'th Nov 2025
Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.
What's Behind Boston Scientific's Optimism for Urology Growth?
08:50am, Monday, 10'th Nov 2025
BSX sees stronger 2026 prospects for Urology, powered by Axonics integration, innovation and global Stone Management momentum.
